Phase III Study of 0.1% Tacrolimus(FK506) Ophthalmic Suspension in Patients With Vernal Keratoconjunctivitis

This study has been completed.

Study NCT00567762 Information provided by Astellas Pharma Inc

First Received: December 3, 2007 Last Updated: February 25, 2009 History of Changes

No Study Results Posted for this Study

Study Status:	This study has been completed.
Study Completion Date:	September 2004
Estimated Primary Completion Date:	No date given